90.96
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $90.96, with a volume of 4.35M.
It is down -0.72% in the last 24 hours and up +0.31% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$91.62
Open:
$93
24h Volume:
4.35M
Relative Volume:
0.55
Market Cap:
$116.35B
Revenue:
$36.36B
Net Income/Loss:
$4.84B
P/E Ratio:
24.41
EPS:
3.7261
Net Cash Flow:
$5.43B
1W Performance:
-3.41%
1M Performance:
+0.31%
6M Performance:
+2.24%
1Y Performance:
-3.49%
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MDT
Medtronic Plc
|
90.96 | 117.19B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
ABT
Abbott Laboratories
|
101.95 | 178.85B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
275.56 | 103.57B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
42.98 | 62.46B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
84.37 | 50.01B | 6.30B | 1.07B | 1.09B | 1.8406 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Resumed | Barclays | Overweight |
| Feb-09-26 | Upgrade | Needham | Hold → Buy |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Jan-30-26 | Resumed | Wells Fargo | Overweight |
| Jan-06-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-19-25 | Upgrade | Goldman | Sell → Neutral |
| Jun-30-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
Medtronic announces first procedures in Europe with Stealth AXiS™ Surgical System - Ortho Spine News
Is Medtronic (NYSE:MDT) Still Cheap on Cash Flow? - Kalkine Media
Medtronic plc stock edges lower as strong Q1 FY2027 figures meet cautious valuation - ad-hoc-news.de
The Manufacturers Life Insurance Company Lowers Stock Holdings in Medtronic PLC $MDT - marketbeat.com
Tidal Investments LLC Purchases 43,207 Shares of Medtronic PLC $MDT - marketbeat.com
Engineers Gate Manager LP Buys 164,637 Shares of Medtronic PLC $MDT - marketbeat.com
National Pension Service Buys 83,277 Shares of Medtronic PLC $MDT - marketbeat.com
Allworth Financial LP Reduces Stock Position in Medtronic PLC $MDT - marketbeat.com
Medtronic plc stock dips after strong Q1 FY2027 figures and steady analyst support - ad-hoc-news.de
Jim Cramer Calls Medtronic (MDT) a “Quandary” as Growth Surges and Diabetes Exit Nears - Yahoo Finance
Keystone Financial Planning Inc. Purchases Shares of 126,411 Medtronic PLC $MDT - marketbeat.com
VIRGINIA RETIREMENT SYSTEMS ET Al Invests $4.09 Million in Medtronic PLC $MDT - marketbeat.com
Medtronic Raised its Outlook as Heart Devices Accelerate, But Can the Momentum Last? - Yahoo Finance UK
Medtronic Is on the Cusp of Becoming a Dividend King. Is the Stock a Buy for Income Investors? - The Motley Fool
Medtronic Raises 2027 Outlook as Broad-Based Growth Gains Momentum - Yahoo Finance
Hedeker Wealth LLC Sells 17,444 Shares of Medtronic PLC $MDT - marketbeat.com
Beacon Investment Advisory Services Inc. Has $6 Million Position in Medtronic PLC $MDT - marketbeat.com
HighTower Advisors LLC Has $30.77 Million Holdings in Medtronic PLC $MDT - marketbeat.com
Medtronic stock heads into the open after a 1.9 percent drop - ad-hoc-news.de
Medtronic Touts AI, Robotics and Ablation Growth at Wells Fargo Conference - marketbeat.com
Medtronic (MDT) Q1 2027 Earnings Call - finance.biggo.com
Medtronic PLC stock outperforms competitors despite losses on the day - marketwatch.com
Medtronic Diabetes at Wells Fargo conference: product wave drives growth - Investing.com India
Medtronic Diabetes at Wells Fargo conference: product wave drives growth By Investing.com - Investing.com UK
Medtronic at Wells Fargo healthcare conference: growth broadens By Investing.com - Investing.com South Africa
Medtronic plc stock gains as fiscal 2027 guidance raised after strong first quarter - AD HOC NEWS
Medtronic at Wells Fargo healthcare conference: growth broadens - Investing.com
Medtronic PLC at Wells Fargo Healthcare Conference Transcript - GuruFocus
Is Medtronic Worth Buying as Growth Improves but Risks Stay Elevated? - theglobeandmail.com
Teleflex Appoints Medtronic Veteran Sean Salmon to Board of Directors - citybiz
Teleflex appoints former Medtronic executive to board By Investing.com - Investing.com Canada
Medtronic (NYSE:MDT): A Dividend Quality Play for Income Investors - ChartMill
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors - stocktitan.net
Amundi Has $455.62 Million Stock Holdings in Medtronic PLC $MDT - marketbeat.com
Medtronic (NYSE:MDT): Can Clinical Progress Outweigh Rate Pressures? - Kalkine Media
Medtronic executives to speak at upcoming investor conferences - marketscreener.com
Medtronic plc (MDT) Stock Analysis: Unpacking a Potential 11.25% Upside in the Medical Device Sector - DirectorsTalk Interviews
Medtronic PLC $MDT Holdings Raised by First Eagle Investment Management LLC - marketbeat.com
Concurrent Investment Advisors LLC Decreases Stock Holdings in Medtronic PLC $MDT - marketbeat.com
Azimuth Capital Investment Management LLC Sells 25,976 Shares of Medtronic PLC $MDT - marketbeat.com
Medtronic Plc Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - moomoo.com
Saudi Central Bank Has $7.03 Million Holdings in Medtronic PLC $MDT - marketbeat.com
Medtronic plc stock gains on strong quarterly figures and guidance - AD HOC NEWS
Medtronic (NYSE:MDT) Flashes a High-Quality Breakout Setup - ChartMill
Oakmont Investment Advisors Inc. Takes $2.10 Million Position in Medtronic PLC $MDT - marketbeat.com
NEOS Investment Management LLC Boosts Holdings in Medtronic PLC $MDT - marketbeat.com
Continuum Advisory LLC Sells 44,102 Shares of Medtronic PLC $MDT - marketbeat.com
Medtronic PLC $MDT Shares Purchased by AXQ Capital LP - marketbeat.com
Two Medtronic executives will answer questions in live webcasts - Stock Titan
Renal Denervation Market Size, Share & Trends Analysis - GlobeNewswire Inc.
Medtronic (NYSE: MDT) Reports $9.76 Billion Revenue and $1.47 Billion Net Income for Q3 2026 - kalkinemedia.com
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):